Clinical Utility and Validation of the Acoustic Voice Quality and Acoustic Breathiness Indexes for Voice Disorder Assessment in English Speakers.

Autor: Castillo-Allendes A; Department of Communicative Sciences and Disorders, Michigan State University, East Lansing, MI 48824, USA.; Department of Communication Sciences and Disorders, University of Iowa, Iowa City, IA 52242, USA., Codino J; Lakeshore Professional Voice Center, Lakeshore Ear, Nose & Throat Center, St. Clair Shores, MI 48081, USA., Cantor-Cutiva LC; Department of Communicative Sciences and Disorders, Michigan State University, East Lansing, MI 48824, USA.; Department of Communication Sciences and Disorders, University of Iowa, Iowa City, IA 52242, USA., Nudelman CJ; Department of Speech and Hearing Science, University of Illinois Urbana-Champaign, Champaign, IL 61820, USA., Rubin AD; Lakeshore Professional Voice Center, Lakeshore Ear, Nose & Throat Center, St. Clair Shores, MI 48081, USA., Barsties V Latoszek B; Speech-Language Pathology, SRH University of Applied Health Sciences, 40210 Düsseldorf, Germany., Hunter EJ; Department of Communicative Sciences and Disorders, Michigan State University, East Lansing, MI 48824, USA.; Department of Communication Sciences and Disorders, University of Iowa, Iowa City, IA 52242, USA.
Jazyk: angličtina
Zdroj: Journal of clinical medicine [J Clin Med] 2023 Dec 14; Vol. 12 (24). Date of Electronic Publication: 2023 Dec 14.
DOI: 10.3390/jcm12247679
Abstrakt: Background: While several acoustic voice metrics are available for clinical voice assessment, there remains a significant need for reliable and ecologically valid tools. The Acoustic Voice Quality Index version 03.01 (AVQI-3) and Acoustic Breathiness Index (ABI) hold potential due to their comprehensive assessment approach, incorporating diverse voice aspects. However, these tools still need to be validated in English-speaking populations.
Methods: This study assessed the discriminatory accuracy and validity of AVQI-3 and ABI in 197 participants, including 148 with voice disorders. Voice samples were collected, followed by AVQI-3 and ABI calculations. Additionally, auditory-perceptual assessments were conducted by a panel of speech-language pathologists.
Results: AVQI-3 and ABI effectively identified disordered voice quality, evidenced by high accuracy (AUCs: 0.84, 0.89), sensitivity, and specificity (thresholds: AVQI-3 = 1.17, ABI = 2.35). Strong positive correlations were observed with subjective voice quality assessments (rs = 0.72, rs = 0.77, p < 0.001).
Conclusions: The study highlights AVQI-3 and ABI as promising instruments for clinically assessing voice disorders in U.S. English speakers, underscoring their utility in clinical practice and voice research.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje